Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Achilles Non-SNIS REGENETEN

NCT: NCT07869121 · ENROLLING_BY_INVITATION

NCT IDNCT07869121
StatusENROLLING_BY_INVITATION
Start Date2026-08-03
Completion2028-12-31
SponsorOrthoCarolina Research Institute, Inc. (OTHER)
First posted
Last updated

Brief Summary

The proposed study addresses this gap by prospectively evaluating patient-reported outcomes, imaging endpoints, and safety through 12 months after BCI-augmented repair in IAT and MSR patients. The purpose is to evaluate clinical outcomes (effectiveness) following the use of REGENETEN to augment Achilles tendon surgical procedures.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑